"Ryan Sperry, VP of integrated client solutions, Basis Technologies: The Trump administration and those close to it have made it clear they’re not fans of how prevalent pharma marketing is in the U.S. Some of the opinions from those like RFK Jr. even suggest getting rid of pharmaceutical advertising altogether, though that would clash with First Amendment protections. I expect the industry will see tighter regulations around how patient data is used in advertising, a trend already occurring with legislation like Washington’s My Health My Data Act, which other states are beginning to adopt."
Read more in MedAdNews.
"The data: Marketers are forging ahead with AI tools, but many are neglecting to determine whether this adoption is actually ...
"It's been more than three years since the media planning and buying industry began adopting generative AI tools into their ...
"Our Best Workplaces lists highlight organizations excelling in creating positive, inclusive, and engaging environments. Explore top companies recognized for exceptional ...
